Fig. 5
From: ZMIZ2 promotes the development of triple-receptor negative breast cancer
ZMIZ2 expression was upregulated in different breast cancer subtypes and associated with poor a prognosis in clinical TNBC patients. A qRT-PCR revealed the upregulation of ZMIZ2 mRNA expression in different breast cancer subtypes. B A Western blot assay showed the upregulation of ZMIZ2 protein expression in different breast cancer subtypes. C An immunohistochemical assay showed the upregulation of ZMIZ2 protein expression in different breast cancer subtypes. Magnification: 200 × ; bar scale: 100 μm. D Kaplan–Meier survival curves for high- and low-expression of ZMIZ2 in clinical patients with TNBC. E: Kaplan–Meier survival curves for high- and low-expression of MCM3 in clinical patients with TNBC. *P < 0.05 and **P < 0.01 when compared with the normal controls